Journal article icon

Journal article

Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study

Abstract:
Background: Adiposity has been characterized as a modifiable risk factor for prostate cancer. Its association with outcomes after prostate cancer diagnosis, however, must be better understood, and more evidence is needed to facilitate the development of lifestyle guidance for patients with prostate cancer. Methods: We investigated the associations between adiposity indices close to prostate cancer diagnosis (up to 2 years before or up to 5 years after diagnosis) and mortality in 1968 men of the European Prospective Investigation into Cancer and Nutrition cohort. Men were followed up for a median of 9.5 years. Cox proportional hazards models were adjusted for age and year of diagnosis, disease stage and grade, and smoking history and stratified by country. Results: Each 5-unit increment in prediagnosis or postdiagnosis body mass index combined was associated with a 30% higher rate of all-cause mortality and a 49% higher rate of prostate cancer–specific mortality. Similarly, each 5-unit increment in prediagnosis body mass index was associated with a 35% higher rate of all-cause mortality and a 51% higher rate of prostate cancer–specific mortality. The associations were less strong for postdiagnosis body mass index, with a lower number of men in analyses. Less clear positive associations were shown for waist circumference, hip circumference, and waist to hip ratio, but data were limited. Conclusions: Elevated levels of adiposity close to prostate cancer diagnosis could lead to higher risk of mortality; therefore, men are encouraged to maintain a healthy weight. Additional research is needed to confirm whether excessive adiposity after prostate cancer diagnosis could worsen prognosis.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1093/jncics/pkae070

Authors


More by this author
Role:
Author
ORCID:
0000-0003-2660-7866
More by this author
Role:
Author
ORCID:
0000-0001-9219-4436
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Cancer Epidemiology Unit
Oxford college:
Lady Margaret Hall
Role:
Author
ORCID:
0000-0003-2294-307X
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Cancer Epidemiology Unit
Oxford college:
Lady Margaret Hall
Role:
Author


More from this funder
Funder identifier:
https://ror.org/03b3akj74


Publisher:
Oxford University Press
Journal:
JNCI Cancer Spectrum More from this journal
Volume:
8
Issue:
5
Article number:
pkae070
Publication date:
2024-08-24
Acceptance date:
2024-08-07
DOI:
EISSN:
2515-5091


Language:
English
Source identifiers:
2270446
Deposit date:
2024-09-19
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP